PRPH - ProPhase Labs, Inc.

0.3626
-0.085   -23.414%

Share volume: 5,493,740
Last Updated: 01-02-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.72%

PREVIOUS CLOSE
CHG
CHG%
$0.45
-0.08
-0.19%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
8%
Profitability 0%
Dept financing 3%
Liquidity 75%
Performance 0%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
178.92%
6 Months
2.17%
1 Year
-13.15%
2 Year
-92.32%
Key data
Stock price
$0.36
P/E Ratio 
0.00
DAY RANGE
$0.30 - $0.47
EPS 
-$0.49
52 WEEK RANGE
$0.08 - $1.15
52 WEEK CHANGE
-$11.02
MARKET CAP 
19.018 M
YIELD 
N/A
SHARES OUTSTANDING 
46.179 M
DIVIDEND
$0.30
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-08-2025
BETA 
-1.57
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
N/A
AVERAGE 30 VOLUME 
N/A
Company detail
CEO: Ted W. Karkus
Region: US
Website: prophaselabs.com
Employees: 130
IPO year: 1997
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. It offers a range of OTC dietary supplements, including Legendz XL for male sexual health; Triple Edge XL, an energy and stamina booster. The company was formerly known as The Quigley Corporation.

Recent news